RNAi Therapeutics

Pages

▼
Showing posts with label essential thrombocythemia. Show all posts
Showing posts with label essential thrombocythemia. Show all posts
Wednesday, March 12, 2014

Imetelstat Off-Target Mechanism Might Be Its Therapeutic Mechanism of Action

›
This morning’s biotech news featured a clinical hold on Geron’s imetelstat , a 13-mer lipid-conjugated N3’-P5’ thio-phosphoroamidate oli...
6 comments:
›
Home
View web version
Powered by Blogger.